Cargando…
Clinical Efficacy Protocol of Yinhuapinggan Granules: A Randomized, Double-Blind, Parallel, and Controlled Clinical Trial Program for the Intervention of Community-Acquired Drug-Resistant Bacterial Pneumonia as a Complementary Therapy
Background: Community-acquired bacterial pneumonia (CABP) is an important health care concern in the worldwide, and is associated with significant morbidity, mortality, and health care expenditure. Streptococcus pneumoniae is the most frequent causative pathogen of CABP. Common treatment for hospita...
Autores principales: | Wang, Jiaoli, Hu, Haoran, Du, Haixia, Luo, Man, Cao, Yilan, Xu, Jiaping, Chen, Tianhang, Guo, Yilei, Li, Qixiang, Chen, Wen, Zhang, Yifei, Han, Jin, Wan, Haitong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279864/ https://www.ncbi.nlm.nih.gov/pubmed/35847015 http://dx.doi.org/10.3389/fphar.2022.852604 |
Ejemplares similares
-
Corrigendum: Clinical efficacy protocol of yinhuapinggan granules: A randomized, double-blind, parallel, and controlled clinical trial program for the intervention of community-acquired drug-resistant bacterial pneumonia as a complementary therapy
por: Wang, Jiaoli, et al.
Publicado: (2022) -
Screening of Antiviral Components of Yinhuapinggan Granule and Protective Effects of Yinhuapinggan Granule on MDCK Cells with Influenza A/H1N1 Virus
por: Chen, Tianhang, et al.
Publicado: (2022) -
Yinhuapinggan granule ameliorates lung injury caused by multidrug-resistant Acinetobacter baumannii via inhibiting NF-κB/NLRP3 pathway
por: Chen, Tianhang, et al.
Publicado: (2023) -
Preliminary study of Yinhuapinggan granule against H1N1 influenza virus infection in mice through inhibition of apoptosis
por: Du, Hai-xia, et al.
Publicado: (2020) -
Comparison of Buyang Huanwu granules and Naoxintong capsules in the treatment of stable angina pectoris: rationale and design of a randomized, blinded, multicentre clinical trial
por: Wang, Yu, et al.
Publicado: (2022)